LCN15 | Lipocalin 15 | Predicted secreted proteins
| | | | | Tissue enhanced |
LRRC31 | Leucine rich repeat containing 31 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MINOS1-NBL1 | MINOS1-NBL1 readthrough | Predicted secreted proteins
| | | | | Tissue enhanced |
MISP | Mitotic spindle positioning | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MNX1 | Motor neuron and pancreas homeobox 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
MTRNR2L8 | MT-RNR2-like 8 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MYB | V-myb avian myeloblastosis viral oncogene homolog | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NEU4 | Sialidase 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
NOXO1 | NADPH oxidase organizer 1 | FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
NPY4R | Neuropeptide Y receptor Y4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
NRARP | NOTCH-regulated ankyrin repeat protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
OTOP2 | Otopetrin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
PDE6A | Phosphodiesterase 6A, cGMP-specific, rod, alpha | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PHGR1 | Proline/histidine/glycine-rich 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PIGZ | Phosphatidylinositol glycan anchor biosynthesis, class Z | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PKIB | Protein kinase (cAMP-dependent, catalytic) inhibitor beta | Predicted intracellular proteins
| | | | | Tissue enhanced |
PLA2G10 | Phospholipase A2, group X | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLA2G2A | Phospholipase A2, group IIA (platelets, synovial fluid) | Enzymes FDA approved drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PPP1R14D | Protein phosphatase 1, regulatory (inhibitor) subunit 14D | Predicted intracellular proteins
| | | | | Tissue enhanced |
PPP1R1B | Protein phosphatase 1, regulatory (inhibitor) subunit 1B | Predicted intracellular proteins
| | | | | Tissue enhanced |
PRR15 | Proline rich 15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RETNLB | Resistin like beta | Predicted secreted proteins
| | | | | Tissue enhanced |
RXFP4 | Relaxin/insulin-like family peptide receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SLC22A18AS | Solute carrier family 22 (organic cation transporter), member 18 antisense | Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC9A2 | Solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SMIM22 | Small integral membrane protein 22 | Predicted membrane proteins
| | | | | Tissue enhanced |
SPINK6 | Serine peptidase inhibitor, Kazal type 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
TFF3 | Trefoil factor 3 (intestinal) | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TMEM171 | Transmembrane protein 171 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM238 | Transmembrane protein 238 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM54 | Transmembrane protein 54 | Predicted membrane proteins
| | | | | Tissue enhanced |
TRABD2A | TraB domain containing 2A | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TRIM31 | Tripartite motif containing 31 | Predicted intracellular proteins
| | | | | Tissue enhanced |
TSPAN1 | Tetraspanin 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
TSPAN8 | Tetraspanin 8 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
UGT1A1 | UDP glucuronosyltransferase 1 family, polypeptide A1 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ZG16 | Zymogen granule protein 16 | Predicted secreted proteins
| | | | | Tissue enhanced |